Patent · US Active

Mad nucleases

US10883095B1 · kind B1 · utility

7Cited by
16References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2020
Grant dateJan 5, 2021
Priority date—
Expiry dateApr 1, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.